29 Recruiting Studies Using Mercaptopurine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Mercaptopurine
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
📍 Boston Children's Hospital — Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist ➔LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
📍 Children's of Alabama — Birmingham, Alabama
Langerhans Cell Histiocytosis
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
📍 Children's Hospital Los Angeles — Los Angeles, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist ➔Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Advanced Kidney Carcinoma
View Study & Checklist ➔Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
📍 University of Chicago Medical Center — Chicago, Illinois
Acute Lymphoblastic Leukemia
View Study & Checklist ➔TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
📍 Phoenix Children's Hospital — Phoenix, Arizona
Lymphoblastic Leukemia
View Study & Checklist ➔Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
📍 Rady Children's Hospital — San Diego, California
T-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Down Syndrome
View Study & Checklist ➔Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 City of Hope at Phoenix — Phoenix, Arizona
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
📍 M D Anderson Cancer Center — Houston, Texas
Blastic Plasmacytoid Dendritic Cell Neoplasm
View Study & Checklist ➔Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔ALL Backbone in AYAs
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔